Industry News
Leading scientist throws in the labcoat
The Australian National University will be using the 12th Frank and Bobbie Fenner Conference to honour the retirement of Emeritus Prof Frank Fenner, the Australian scientist who oversaw the eradication of smallpox.
[ + ]Exploring ‘bench to bedside’ investment opportunities
The Health Partnerships for the Future event, hosted by UQ’s Faculty of Health Sciences, will be held on Tuesday 30 October at Brisbane Customs House.
[ + ]Muscle stem cells on SCS menu
Stem Cell Sciences adds pericyte cell types to list of products for research. [ + ]
Binocular vision gene sighted
A team of international researchers have identified an important gene responsible for binocular vision.
[ + ]US brain cancer vaccine trial underway
A clinical trial evaluating a vaccine in patients with newly diagnosed brain cancer has begun at the New York University Medical Center. [ + ]
AusBiotech report: Novotech gets $8m boost
$8 million injection of funds to allow ANZ CRO Novotech to expand into Asia. [ + ]
A gene for moonlight romance?
A team of Australian and Israeli researchers has possibly discovered the aphrodisiac for the biggest moonlight sex event on the planet.
[ + ]AusBiotech report: Farmacule scores big with Syngenta
Brisbane's Farmacule will partner Syngenta and QUT to develop sugarcane-derived biofuels. [ + ]
AusBiotech report: Gates offers novel grants for novel ideas
Fast-track grants of $100,000 available to small projects addressing big needs from Bill Gates Foundation. [ + ]
AusBiotech report: Second generation biotech
Research Australia report says the source of original research for biotech companies is moving from the public to the private. [ + ]
Arthritis genes identified
A Queensland scientist has discovered two genes responsible for developing a form of arthritis known as ankylosing spondylitis, according to research published in the latest edition of
[ + ]AusBiotech profile: ReWire Therapies
ReWire Therapies can probably boast one of the most impressive groups of company directors to be found in any biotechnology venture in Australia. [ + ]
AusBiotech special: how Oncaidia hopes to target cancer
Adelaide company Oncaidia is developing a novel monoclonal antibody it hopes will target cancer by tracking down the La protein and letting loose a firestorm. [ + ]
Boning up on mesenchymal stem cells
As it begins Phase IIa clinical trials, Mesoblast is riding high: its share price is climbing, its market capitalisation is booming and all that promise seems to be coming good. [ + ]
Antarctic genes incorporated into frost-resistant wheat
The Molecular Plant Breeding Cooperative Research Centre (MPBCRC) has announced its intention to develop genetically modified (GM) wheat with enhanced tolerance to frost, to help combat concerns over frost damage to crops.
[ + ]